You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
X-Ray Detectors for Synchrotron-Based Structural Biology
SBC: AREA DETECTOR SYSTEMS CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Development is proposed of an x-ray Pixel Array Detector (PAD) consisting approximately of 2,000 x 2,000 pixels to enhance macromolecular crystallographic data collection at synchrotron sources. A PAD consists of an x-ray sensing integrated circuit layer bonded to a pixel electronics layer such that each pixel has its own processing electronics. PADs promise t ...
SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
A Tunable, Tabletop, Synchrotron Light Source
SBC: LYNCEAN TECHNOLOGIES, INC. Topic: N/AN/A
SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
Risperidone Subcutaneous Implant
SBC: DELPOR INC Topic: 101The objective of the proposed study is to develop a subcutaneous implant of risperidone that provides consistent therapeutic blood levels of the drug for 6 months after a single administration. The device is implanted during a simple, 10-minute, in-office procedure with local anesthetic. The benefits of the product include improved medication adherence, fewer relapses, ability to withdraw the medi ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Fludase for Prevention of Influenza
SBC: Nexbio, Inc. Topic: N/ADESCRIPTION (provided by applicant): Influenza is characterized by recurrent annual epidemics and periodic major worldwide pandemics. Because of the high disease-related morbidity and mortality, direct and indirect socio-economic impacts of influenza are enormous. In the last 100 years, there have been 3 major influenza pandemics. It has been about thirty years since the last pandemic. A new pand ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Prophylactic Anthrax Toxin Vaccine
SBC: VICAL, INC. Topic: N/ADESCRIPTION (provided by applicant): Vical Inc. seeks SBIR Phase II funding to develop and produce a licensable prophylactic anthrax vaccine. This project will move on an accelerated but realistic timeline with plans for human clinical trials to begin in September 2003. Although many candidate vaccines are being studied for anthrax prevention or post-exposure prophylaxis, the Vical approach has ...
STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
SBC: LENTIGEN CORPORATION Topic: NCIDESCRIPTION (provided by applicant): This Phase II proposal is a continuation of our Phase I award, Lentiviral Vectors for TCR Immunotherapy Targeted to Melanoma. We have successfully achieved the milestones laid out in our initial application. We generated a lentiviral gene vector capable of expressing a T cell receptor (TCR) specific for the tyrosinase:368-376 epitope, and demonstrated the act ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Botulinum Toxin Plantibodies
SBC: Planet Biotechnology Incorporated Topic: N/ADESCRIPTION (provided by applicant): The ultimate goal of the research described in this application is to develop an economical, safe and effective countermeasure to defend the American public from a bioterrorist attack by botulinum toxin. We aim to be the manufacturer of an antibody or antibody mixture, derived form transgenic plants; that win effectively neutralize botulinum toxin and will supp ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Portable Hearing Laboratory- CRP
SBC: BATANDCAT Topic: YIn the parent Phase II project (R44DC016247; PI: C. Pavlovic) we successfully developed a portable platform for developing and testing new hearing aid technology. This Portable Hearing Laboratory, or PHL, has now been acquired and is being used by a number of leading university laboratories and other research centers and their feedback has been extremely positive. The device features a central uni ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Novel peptide-impregnated hydrogel as a wound healing device
SBC: SCARLESS LABORATORIES INC Topic: NIDCRPROJECT SUMMARY / ABSTRACT Wounds healing with exuberant fibrotic scarring or wounds that fail to heal represent two opposing ends of the wound repair spectrum. Fibrotic scarring in highly visible areas after craniofacial reconstruction can result in severe functional and cosmetic disability. Similarly, wound dehiscence—wound tissue separation due to a failure to heal with adequate tensile stren ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Kinetic Biomarker for CLL Prognosis
SBC: KINEMED, INC. Topic: N/ADESCRIPTION (provided by applicant) PHASE I The need for reliable biomarkers in cancer is clear, for areas including prognosis, stratification, therapeutic monitoring and drug discovery and approval. The fundamental disorder in cancer is altered cell k
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health